Matthew Douglass
No Rating Available
(Learn About Our Rating System)

Matthew Douglass, DO

Clinical Locations

Primary Children's Hospital

Salt Lake City
801-662-1000

  • Dr. Matthew Douglass received his medical degree from the University of North Texas Health Science Center in Fort Worth, Texas, completed his Pediatric Residency at the University of Nebraska in Omaha, Nebraska, and his Neonatal-Perinatal Medicine Fellowship at the University of Utah. Dr. Douglass is board certified in Pediatrics and board eligible for Neonatal-Perinatal Medicine.

    Dr. Douglass provides care for premature and critically ill infants in the Neonatal Intensive Care Units at the University of Utah, Primary Children’s Hospital, and Intermountain Medical Center.

    His clinical and research interests include neonatal lung disease and pulmonary hypertension with a focus on the mechanisms of right heart failure in neonatal pulmonary hypertension.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Neonatal-Perinatal Medicine)

  • Dr. Matthew Douglass received his medical degree from the University of North Texas Health Science Center in Fort Worth, Texas, completed his Pediatric Residency at the University of Nebraska in Omaha, Nebraska, and his Neonatal-Perinatal Medicine Fellowship at the University of Utah. Dr. Douglass is board certified in Pediatrics and board eligible for Neonatal-Perinatal Medicine.

    Dr. Douglass provides care for premature and critically ill infants in the Neonatal Intensive Care Units at the University of Utah, Primary Children’s Hospital, and Intermountain Medical Center.

    His clinical and research interests include neonatal lung disease and pulmonary hypertension with a focus on the mechanisms of right heart failure in neonatal pulmonary hypertension.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Neonatology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Neonatal-Perinatal Medicine)

    Education history

    Fellowship Neonatology - University of Utah Postdoctoral Clinical Fellow
    Pediatrics - University of Nebraska Medical Center Resident
    Doctoral Training University of North Texas Health Science Center D.O.
    Mechanical Engineering - University of Texas BSME

    Selected Publications

    Journal Article

    1. Douglass MS, Kaplowitz MR, Zhang Y, Fike CD (2023). Impact of l-citrulline on nitric oxide signaling and arginase activity in hypoxic human pulmonary artery endothelial cells. Pulm Circ, 13(2), e12221. (Read full article)
    2. McKinney RL, Napolitano N, Levin JJ, Kielt MJ, Abman SH, Guaman MC, Rose RS, Courtney SE, Matlock D, Agarwal A, Leeman KT, Sanlorenzo LA, Sindelar R, Collaco JM, Baker CD, Hannan KE, Douglass M, Eldredge LC, Lai K, McGrath-Morrow SA, Tracy MC, Truog W, Lewis T, Murillo AL, Keszler M (2022). Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study. J Pediatr, 242, 248-252.e1. (Read full article)
    3. Douglass M, Dikalova A, Kaplowitz MR, Zhang Y, Cunningham G, Summar M, Fike CD (2021). Folic acid, either solely or combined with L-citrulline, improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. Physiol Rep, 9(21). (Read full article)
    4. Douglass MS, Zhang Y, Kaplowitz MR, Fike CD (2021). L-citrulline increases arginase II protein levels and arginase activity in hypoxic piglet pulmonary artery endothelial cells. Pulm Circ, 11(2), 20458940211006289. (Read full article)
    5. Douglass MS, Zhang Y, Kaplowitz MR, Fike CD (2021). L-citrulline increases arginase II protein levels and arginase activity in hypoxic piglet pulmonary artery endothelial cells. Pulm Circ, 11(2). (Read full article)